论文部分内容阅读
目的探讨安列克在预防剖宫产产后出血中的临床应用价值。方法选取我院收治的240例有产后出血倾向的孕妇,随机将其分为观察组(120例)和对照组(120例),两组均在胎儿娩出后给予常规静滴催产素,对照组加用舌下含服米索前列醇,观察组加用肌肉注射安列克,比较两组产后出血发生率、产后2h及24h出血量、不良反应。结果观察组在产后出血发生率和产后2h及24h出血量均低于对照组,两组差异具有统计学意义(P<0.05);观察组药物不良反应发生率与对照组无差异,不具有统计学意义(P>0.05)。结论安列克对于有产后出血倾向的剖腹产患者具有明显的临床疗效,具有十分重要的临床价值。
Objective To investigate the clinical value of Allil in the prevention of bleeding after cesarean section. Methods A total of 240 pregnant women with postpartum hemorrhagic tendency who were admitted to our hospital were randomly divided into observation group (120 cases) and control group (120 cases). Both groups were given routine intravenous oxytocin after birth and control group Plus sublingual misoprostol, the observation group plus intramuscular injection of leremy, compared the incidence of postpartum hemorrhage between the two groups, 2h and 24h postpartum hemorrhage, adverse reactions. Results The incidence of postpartum hemorrhage and the amount of hemorrhage 2 h and 24 h postpartum in the observation group were significantly lower than those in the control group (P <0.05). There was no difference between the observation group and the control group Significance (P> 0.05). Conclusion Allilek has obvious clinical effect on patients with caesarean section who have the tendency of postpartum hemorrhage and has very important clinical value.